HK1013289A1 - Naphthalene derivatives as prostaglandin 12 agonists - Google Patents
Naphthalene derivatives as prostaglandin 12 agonists Download PDFInfo
- Publication number
- HK1013289A1 HK1013289A1 HK98114588A HK98114588A HK1013289A1 HK 1013289 A1 HK1013289 A1 HK 1013289A1 HK 98114588 A HK98114588 A HK 98114588A HK 98114588 A HK98114588 A HK 98114588A HK 1013289 A1 HK1013289 A1 HK 1013289A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- salt
- hydroxy
- formula
- naphthyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/02—Compounds containing any of the groups, e.g. carbazates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9404734A GB9404734D0 (en) | 1994-03-10 | 1994-03-10 | Heterocyclic compounds |
GB9404734.7 | 1994-03-10 | ||
GB9407036A GB9407036D0 (en) | 1994-04-08 | 1994-04-08 | Naphthalene derivatives |
GB9407036.4 | 1994-04-08 | ||
PCT/JP1995/000373 WO1995024393A1 (en) | 1994-03-10 | 1995-03-08 | Naphthalene derivatives as prostaglandin i2 agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1013289A1 true HK1013289A1 (en) | 1999-08-20 |
HK1013289B HK1013289B (en) | 2002-01-18 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
TW282456B (xx) | 1996-08-01 |
JP3245864B2 (ja) | 2002-01-15 |
GR3037080T3 (en) | 2002-01-31 |
RU2155188C2 (ru) | 2000-08-27 |
PT749424E (pt) | 2002-03-28 |
CN1057522C (zh) | 2000-10-18 |
HUT75226A (en) | 1997-04-28 |
US5863918A (en) | 1999-01-26 |
EP0749424A1 (en) | 1996-12-27 |
HU224822B1 (en) | 2006-02-28 |
ATE205479T1 (de) | 2001-09-15 |
US5763489A (en) | 1998-06-09 |
WO1995024393A1 (en) | 1995-09-14 |
KR970701698A (ko) | 1997-04-12 |
CA2185104A1 (en) | 1995-09-14 |
DE69522676D1 (de) | 2001-10-18 |
CN1147250A (zh) | 1997-04-09 |
JPH09509958A (ja) | 1997-10-07 |
EP0749424B1 (en) | 2001-09-12 |
DE69522676T2 (de) | 2002-04-18 |
DK0749424T3 (da) | 2001-11-26 |
KR100383305B1 (ko) | 2003-11-01 |
HU9602466D0 (en) | 1996-11-28 |
AU688871B2 (en) | 1998-03-19 |
AU1861895A (en) | 1995-09-25 |
ES2160156T3 (es) | 2001-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0749424B1 (en) | Naphthalene derivatives as prostaglandin i2 agonists | |
AU686286B2 (en) | 4,5-diaryloxazole derivatives | |
US6300344B1 (en) | Heterocyclic compounds | |
US20050267206A1 (en) | Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders | |
WO2000016760A2 (en) | New use of prostaglandin e2 antagonists | |
TW200811110A (en) | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor | |
WO1994026738A1 (en) | N'-heterocyclyl-n-benzofuranyl urea derivatives and their analogs as acat inhibitors | |
CZ373096A3 (en) | Trisubstituted phenyl derivatives, process of their preparation and pharmaceutical compositions containing thereof | |
HU224823B1 (en) | Substituted benzamidines,process for preparing the said compds. and pharmaceutical compns. contg. them | |
EP0223593A2 (en) | Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation | |
US7902394B2 (en) | Calcilytic compounds | |
JPH10500965A (ja) | ヒドロキシルアミン誘導体及びメタロプロテイナーゼ阻害剤としてのその用途 | |
FR2521992A1 (fr) | Nouveaux composes de pyridine utiles comme medicaments | |
EP1042277B1 (en) | Naphthalene derivatives | |
WO1992009561A1 (en) | New amide derivatives | |
WO2000012462A1 (en) | Aminoalcohol derivatives and their use as beta 3 adrenergic agonists | |
HK1013289B (en) | Naphthalene derivatives as prostaglandin 12 agonists | |
WO1994018165A1 (en) | Sulfonamide compounds as opioid k-receptor agonists | |
US6384072B1 (en) | Benzocycloheptene derivatives | |
US4980362A (en) | 4-substituted-2-alkoxytetrahydrofuran derivatives | |
EP0718307A2 (fr) | Dérivés de 1-oxo-2-(phénylsulfonyl-amino)pentylpipéridine, leur préparation et leur application en thérapeutique | |
WO1994025427A1 (en) | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders | |
JP2003522814A (ja) | アミノアルコール誘導体 | |
EP1453796B1 (fr) | Propanolaminomethyltetralines, leur preparation et composition pharmaceutiques en contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20060308 |